Cetuximab Antibody
Cetuximab (C225) is a monoclonal antibody targeting the human epidermal growth factor receptor (EGFR) with high affinity (Kd=0.201 nM) . It inhibits tumor cell proliferation and induces apoptosis, making it a key tool for in vitro and in vivo cancer research, particularly in studying EGFR-driven oncology models.
Product Specifications
Product Name Alternative
Inhibit, Inhibitor, HER1, EGFR, Epidermal growth factor receptor, ErbB-1, C225, C-225, C 225, anti-EGFR, Cetuximab, Cetuximab (anti-EGFR)
Target
EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
5.62 mg/mL
Purity
95.70% (May vary between batches)
Molecular Weight
145.54 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cluster of Differentiation 301 (CD301) Antibody (Biotin)
Avian Influenza A H7N9 Hemagglutinin Antibody
CRABP2 (CRABP-2, CRABPII, CRABP-II, Cellular Retinoic Acid-Binding Protein 2, Cellular Retinoic Acid-binding Protein II) (MaxLight 550)